secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAGENICS INC (OGEN)
CIK:        0001174940
Form:       8-K
Filed at:   2023-04-10T23:59:59+00:00
Accession:  0001493152-23-011744
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 4.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oragenics restates 2022 interim financials; R&D prepayment errors, expects material weaknesses
--------------------------------------------------------------------------------

- Restating Q1, Q2, Q3 2022 financials; improperly expensed R&D prepayments to vendors instead of recording as prepaid assets.
- Overstated R&D expense and understated assets; no estimate of restatement amount yet provided.
- Expects to report one or more material weaknesses in internal control over financial reporting.
- Press releases and other communications covering Non-Reliance Periods should no longer be relied upon.
- Company working to complete restatement and file 2022 Form 10-K as soon as practicable.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1174940/000149315223011744/0001493152-23-011744-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1174940/000149315223011744/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-011744

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer